PHARE CHU
The computed 12-month bankruptcy probability of PHARE CHU is 0.1% (very low). The 2025 annual accounts show equity of €7k and a net result of €-5k. Equity is shrinking by ~96.5% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2026. Its solvency ranks better than 89% of 2219 sector peers (fiscal year 2025). The company has been active since 1994 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €7k |
| Net result | €-5k |
| Better than sector | 89% |
| Active | 31 yrs |
Strong profile, led by solvency.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 91.9% | 58.2% | |
| Net result | €-5k | €60k | |
| Equity | €7k | €74k | |
| Gross operating margin | €-4k | €95k | |
| Total assets | €8k | €187k |
Show 5 other metrics
| Fiscal year | 2025 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | - |
| Net profit | €-5k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €8k |
| Equity | €7k |
| Debt | €620 |
| of which ≤ 1y | €220 |
| of which > 1y | - |
| Working capital | €7k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 34.67 |
| Quick ratio | 34.67 |
| Working capital ratio | 97.1% |
| Solvency | 91.9% |
| Debt / equity | 0.09 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -61.2% |
| ROE | -66.6% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (17 line items)
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €8k |
| Current assets | 29/58 | €8k |
| Cash & bank | 54/58 | €8k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €8k |
| Equity | 10/15 | €7k |
| Contributions / capital | 10/11 | €18k |
| Reserves | 13 | €2k |
| Accumulated profits (losses) | 14 | €-13k |
| Amounts payable | 17/49 | €620 |
| Amounts payable within one year | 42/48 | €220 |
| Trade debts payable within one year | 44 | €220 |
| Income statement | ||
| Gross operating margin | 9900 | €-4k |
| Operating result | 9901 | €-4k |
| Financial charges | 65 | €479 |
| Result before taxes | 9903 | €-5k |
| Net result for the period | 9904 | €-5k |
| Result to be appropriated | 9905 | €-5k |
| NACE primary | Activiteiten van medisch specialisten(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 26-11-1994 |
| Status | Active |
| Postal code | 4130 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62101B0033/00G000 | Wallonia | 691 m² | 1 · 202 m² | 11.3 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 9 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
20-12-2023 Capital decrease of €12,395.10 to €3,718.51
- €16.113,61 → €3.718,51
Technical details
{
"events": [
{
"kind": "capital_decrease",
"after_eur": 3718.51,
"delta_eur": -12395.1,
"before_eur": 16113.61,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "DEFRESNE Aline",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "FRANSSEN Colette",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "KABA Abdourahamme",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "KIRSCH Murielle",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "LECOQ Jean-Pierre",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "LIBRECHT Dominique",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "LOIS Fernande",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "ROUSSEAU Anne-Fran\u00E7oise",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "VENNEMAN Ingrid",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "CANIVET Jean-Luc",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": "distribution_to_shareholders",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": 5000,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": 1239.51,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "vzw_capital_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Jean-Michel GAUTHY",
"firm_city": null,
"firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
"office_city": "Herstal",
"is_associated": true
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-12-20",
"filing_date": "2023-12-18",
"act_kind_objet": "Objet de l\u0027acte"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-12-15",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "LIBRA \u2013 AUDIT \u0026 ASSURANCE",
"ibr_number": null,
"mission_type": "fusion_special_report",
"individual_name": "ESSAHELI Hanine"
},
"subject_company": {
"kbo": "0454.360.965",
"name_full": "ANESTHESIE-REANIMATION MARCEL HANQUET",
"legal_form": "Soci\u00E9t\u00E9 coop\u00E9rative \u00E0 responsabilit\u00E9 illimit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition de l\u2019assembl\u00E9e comprenant le rapport de l\u2019organe d\u2019administration justifiant la proposition de transformation, le rapport du r\u00E9viseur d\u2019entreprise sur l\u2019\u00E9tat r\u00E9sumant la situation active et passive de la soci\u00E9t\u00E9 annex\u00E9 au rapport de l\u2019organe d\u2019administration et 12 procurations",
"la coordination des statuts"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "BONHOMME Vincent",
"role": null,
"n_shares": 500,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "DEWANDRE Pierre-Yves",
"role": null,
"n_shares": 500,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "HANS Gr\u00E9gory",
"role": null,
"n_shares": 500,
"share_class": null
}
],
"share_classes_after": []
}| Legal nameFR | PHARE CHU |